Willow Biosciences Inc.
CANSF
$0.0038
$0.001140.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -641.50K | -913.50K | -1.23M | -1.75M | -1.78M |
| Total Depreciation and Amortization | 520.10K | 230.20K | 258.00K | 261.10K | 270.50K |
| Total Amortization of Deferred Charges | 4.30K | -- | -- | -- | 6.60K |
| Total Other Non-Cash Items | -20.70K | 104.80K | 106.00K | 48.20K | 50.00K |
| Change in Net Operating Assets | 162.20K | -87.20K | 333.20K | 142.40K | 624.00K |
| Cash from Operations | -237.90K | -665.70K | -535.70K | -1.30M | -830.60K |
| Capital Expenditure | 0.00 | -14.70K | -- | -- | -32.30K |
| Sale of Property, Plant, and Equipment | 0.00 | -- | -- | 100.10K | 5.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.10K | -65.30K | -- | -- | 31.60K |
| Cash from Investing | 37.10K | -79.90K | -- | 100.10K | 4.40K |
| Total Debt Issued | -1.91M | 1.09M | 547.00K | -- | 499.00K |
| Total Debt Repaid | -264.00K | -198.00K | -200.00K | -198.00K | -191.00K |
| Issuance of Common Stock | 0.00 | 2.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.90M | -253.00K | -1.00K | 269.00K | 23.00K |
| Cash from Financing | -196.50K | 472.20K | 252.90K | 52.70K | 243.30K |
| Foreign Exchange rate Adjustments | 21.40K | -3.70K | 2.90K | 13.40K | -30.90K |
| Miscellaneous Cash Flow Adjustments | -- | 401.10K | -399.70K | -- | 221.20K |
| Net Change in Cash | -375.80K | 123.90K | -679.60K | -1.13M | -392.50K |